Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women

    Nature medicine, 2018.

    Cited by: 13|Bibtex|Views2|Links
    WOS

    Abstract:

    Several clinical trials have demonstrated that antiretroviral (ARV) drugs taken as pre-exposure prophylaxis (PrEP) can prevent HIV infection, with the magnitude of protection ranging from -49 to 86% (refs. ). Although these divergent outcomes are thought to be due primarily to differences in product adherence, biological factors likely co...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments